Overview
Stefan Bohlander practices in Auckland, New Zealand. Mr. Bohlander is rated as an Experienced expert by MediFind in the treatment of Subependymal Nodular Heterotopia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Craniofrontonasal Dysplasia, and Acute Lymphoblastic Leukemia (ALL).
His clinical research consists of co-authoring 107 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Mr. Bohlander isElite. Learn about Acute Myeloid Leukemia (AML).
- Distinguished
- LeukemiaMr. Bohlander isDistinguished. Learn about Leukemia.
- Advanced
- Craniofrontonasal DysplasiaMr. Bohlander isAdvanced. Learn about Craniofrontonasal Dysplasia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Bohlander isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaMr. Bohlander isExperienced. Learn about Acute Promyelocytic Leukemia.
- Cerebral HypoxiaMr. Bohlander isExperienced. Learn about Cerebral Hypoxia.
- Chronic B-Cell Leukemia (CBCL)Mr. Bohlander isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Bohlander isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Mr. Bohlander isExperienced. Learn about Chronic Myelogenous Leukemia (CML).